Re: COVID trial now in CTD
|
4
|
Resverlogix Corp.
|
May 15, 2021 01:48PM
|
Re: Covid China
|
5
|
Resverlogix Corp.
|
Mar 30, 2022 12:57AM
|
Re: Cost of Dilution/Public Offering v Private Placement
|
6
|
Resverlogix Corp.
|
Oct 08, 2020 03:49AM
|
Re: Cost of Dilution/Public Offering v Private Placement
|
4
|
Resverlogix Corp.
|
Oct 08, 2020 01:04PM
|
Re: Cost of Dilution/Public Offering v Private Placement
|
4
|
Resverlogix Corp.
|
Oct 08, 2020 01:45PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
10
|
Resverlogix Corp.
|
Dec 16, 2021 01:14PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
5
|
Resverlogix Corp.
|
Dec 13, 2021 12:14PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
6
|
Resverlogix Corp.
|
Dec 13, 2021 01:24PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
7
|
Resverlogix Corp.
|
Dec 13, 2021 01:49PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
6
|
Resverlogix Corp.
|
Dec 13, 2021 02:00PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
8
|
Resverlogix Corp.
|
Dec 13, 2021 03:16PM
|
Re: Convertible Debenture
|
3
|
Zenith Epigenetics
|
May 30, 2020 12:07PM
|
Re: Connecting the Dots II - Royalty Preferred Shares
|
3
|
Resverlogix Corp.
|
Feb 17, 2019 01:17PM
|
Re: Compensation
|
2
|
Resverlogix Corp.
|
May 21, 2022 01:39PM
|
Re: coldn brought this up on the rvx board...
|
3
|
Zenith Epigenetics
|
May 13, 2019 11:05PM
|
Re: Code of Conduct
|
1
|
Resverlogix Corp.
|
Sep 12, 2019 04:17PM
|
Re: Close competitor…
|
6
|
Resverlogix Corp.
|
Oct 19, 2021 04:29PM
|
Re: Classifying/taxonomy mCRPC patients
|
5
|
Zenith Epigenetics
|
Apr 20, 2019 06:53PM
|
Re: CityNews cover
|
6
|
Resverlogix Corp.
|
Jan 31, 2022 01:32PM
|
Re: Checking the chart and seeing another pennant, contractions coming quicker....
|
1
|
Resverlogix Corp.
|
May 13, 2019 12:38PM
|